Cystatin C and Cognitive Impairment 10 Years Later in Older Women

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 70, Issue 6, 2015, Pages 771-778

  Slinin, Yelena ^a,b   Peters, Katherine W ^c   Ishani, Areef ^a,b   Yaffe, Kristine ^d   Fink, Howard A ^a,b,e   Stone, Katie L ^c   Steffes, Michael ^a   Ensrud, Kristine E ^a,b,e  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VA MEDICAL CENTER   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Division of Epidemiology and Community Health   (United States)

Author keywords

Aging; Cognitive impairment; Cystatin C

Indexed keywords

CREATININE; CYSTATIN C;

AGED; AGING; BLOOD; DEMENTIA; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; LONGITUDINAL STUDY; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; PROSPECTIVE STUDY; UNITED STATES;

AGED; AGING; CREATININE; CYSTATIN C; DEMENTIA; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LONGITUDINAL STUDIES; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; UNITED STATES;

EID: 84954154842     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glu189     Document Type: Article

References (43)

1. Garrett N, Martini EM. The boomers are coming: A total cost of care model of the impact of population aging on the cost of chronic conditions in the United States. Dis Manag. 2007;10:51-60.
2. Quentin W, Riedel-Heller SG, Luppa M, Rudolph A, König HH. Cost-ofillness studies of dementia: A systematic review focusing on stage dependency of costs. Acta Psychiatr Scand. 2010;121:243-259.
3. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038-2047.
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.
5. Shlipak MG, Katz R, Sarnak MJ, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006;145:237-246.
6. Bowling CB, Muntner P. Epidemiology of chronic kidney disease among older adults: A focus on the oldest old. J Gerontol A Biol Sci Med Sci. 2012;67:1379-1386.
7. Kurella M, Chertow GM, Luan J, Yaffe K. Cognitive impairment in chronic kidney disease. J Am Geriatr Soc. 2004;52:1863-1869.
8. Kurella M, Chertow GM, Fried LF, et al. Chronic kidney disease and cognitive impairment in the elderly: The health, aging, and body composition study. J Am Soc Nephrol. 2005;16:2127-2133.
9. Kurella M, Yaffe K, Shlipak MG, Wenger NK, Chertow GM. Chronic kidney disease and cognitive impairment in menopausal women. Am J Kidney Dis. 2005;45:66-76.
10. O'Hare AM, Walker R, Haneuse S, et al. Relationship between longitudinal measures of renal function and onset of dementia in a community cohort of older adults. J Am Geriatr Soc. 2012;60:2215-2222.
11. Seliger SL, Siscovick DS, Stehman-Breen CO, et al. Moderate renal impairment and risk of dementia among older adults: The Cardiovascular Health Cognition Study. J Am Soc Nephrol. 2004;15:1904-1911.
12. Slinin Y, Paudel ML, Ishani A, et al.; Osteoporotic Fractures in Men Study Group. Kidney function and cognitive performance and decline in older men. J Am Geriatr Soc. 2008;56:2082-2088.
13. Anand S, Johansen KL, Kurella Tamura M. Aging and chronic kidney disease: The impact on physical function and cognition. J Gerontol A Biol Sci Med Sci. 2014;69:315-322.
14. Davison AM. Renal disease in the elderly. Nephron. 1998;80:6-16.
15. Giannelli SV, Patel KV, Windham BG, Pizzarelli F, Ferrucci L, Guralnik JM. Magnitude of underascertainment of impaired kidney function in older adults with normal serum creatinine. J Am Geriatr Soc. 2007;55:816-823.
16. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis. 2001;37:79-83.
17. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352:2049-2060.
18. Gauthier S, Kaur G, Mi W, Tizon B, Levy E. Protective mechanisms by cystatin C in neurodegenerative diseases. Front Biosci (Schol Ed). 2011;3:541-554.
19. Gauthier SA, Tizon B, Sahoo S, Levy E. In vitro assays measuring protection by proteins such as cystatin C of primary cortical neuronal and smooth muscle cells. Methods Mol Biol. 2012;849:275-287.
20. Kaeser SA, Herzig MC, Coomaraswamy J, et al. Cystatin C modulates cerebral beta-amyloidosis. Nat Genet. 2007;39:1437-1439.
21. Sastre M, Calero M, Pawlik M, et al. Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation. Neurobiol Aging. 2004;25:1033-1043.
22. Yaffe K, Lindquist K, Shlipak MG, et al. Cystatin C as a marker of cognitive function in elders: Findings from the health ABC study. Ann Neurol. 2008;63:798-802.
23. Sarnak MJ, Katz R, Fried LF, et al.; Cardiovascular Health Study. Cystatin C and aging success. Arch Intern Med. 2008;168:147-153.
24. Sundelöf J, Arnlöv J, Ingelsson E, et al. Serum cystatin C and the risk of Alzheimer disease in elderly men. Neurology. 2008;71:1072-1079.
25. Erlandsen EJ, Randers E, Kristensen JH. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest. 1999;59:1-8.
26. Inker LA, Eckfeldt J, Levey AS, et al. Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis. 2011;58:682-684.
27. Inker LA, Schmid CH, Tighiouart H, et al.; CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20-29.
28. Levey AS, Stevens LA, Schmid CH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
29. Yaffe K, Middleton LE, Lui LY, et al. Mild cognitive impairment, dementia, and their subtypes in oldest old women. Arch Neurol. 2011;68:631-636.
30. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
31. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucson, AZ: Neuropsychology Press; 1985.
32. McDowell I, Kristjansson B, Hill GB, Hébert R. Community screening for dementia: The Mini Mental State Exam (MMSE) and Modified Mini-Mental State Exam (3MS) compared. J Clin Epidemiol. 1997;50:377-383.
33. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test-Second Edition (CVLT-II). San Antonio, TX: Psychological Corporation; 2000.
34. Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York, NY: The Psychological Corporation; 1988.
35. Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, NY: Oxford University Press; 1991.
36. Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): Socio-demographic correlates, reliability, validity and some norms. Psychol Med. 1989;19:1015-1022.
37. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 2000.
38. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol. 1999;56:303-308.
39. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985-1992.
40. Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull. 1988;24:709-711.
41. Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 1983;26:1346-1353.
42. Yaffe K, Kurella-Tamura M, Ackerson L et al. Higher levels of cystatin c are associated with worse cognitive function in older adults with chronic kidney disease: The Chronic Renal Insufficiency Cohort Cognitive Study. J Am Geriatr Soc. 2014 Sep;62:1623-1629.
43. Ghidoni R, Benussi L, Glionna M, et al. Plasma cystatin C and risk of developing Alzheimer's disease in subjects with mild cognitive impairment. J Alzheimers Dis. 2010;22:985-991.